EYEN
Eyenovia Inc
Price:  
4.21 
USD
Volume:  
2,318,011.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EYEN WACC - Weighted Average Cost of Capital

The WACC of Eyenovia Inc (EYEN) is 9.8%.

The Cost of Equity of Eyenovia Inc (EYEN) is 9.30%.
The Cost of Debt of Eyenovia Inc (EYEN) is 14.15%.

Range Selected
Cost of equity 5.60% - 13.00% 9.30%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 21.30% 14.15%
WACC 5.4% - 14.3% 9.8%
WACC

EYEN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.37 1.45
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.60% 13.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1.14 1.14
Cost of debt 7.00% 21.30%
After-tax WACC 5.4% 14.3%
Selected WACC 9.8%

EYEN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for EYEN:

cost_of_equity (9.30%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.37) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.